ArticleEuropean journal of heart failure2022

Sodium-glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction - lessons from clinical trials. Letter regarding the article 'Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF'.

Wolfram Doehner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.